¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-04-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-04-18
±³À°ÀÏÀÚ : 2024-04-18
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê

±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ´ëÇÑÇǺΰúÇÐȸ
¿¬¶ôó : 02-3473-0284  

À̸ÞÀÏ : kda@derma.or.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 26 ½Ã°£ 35ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í Á¤È¸¿ø 80,000 / ÁØȸ¿ø 40,000 / ºñȸ¿ø 500,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:30~12:35 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:35~13:20 Skin disease treatment targeting itch Takeshi Nakahara(Kyushu University Fukuoka Japan)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:20~13:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:00~15:25 ÃÊ·Ï Epigenetics in skin inflammation ±è¶ô±Õ(¿¬¼¼´ë ÀÇ»ý¸í°úÇкÎ)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:25~15:40 ÃÊ·Ï Alcohol and smoking in skin disorders À̼־Ï(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:40~15:55 ÃÊ·Ï Exercise in skin health Á¤ÁعÎ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 15:55~16:10 ÃÊ·Ï Systemic photoprotection and skin cancer prevention ±èÁ¤Àº(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 16:10~16:20 Panel discussion ±èÁ¤Àº ±è¶ô±Õ ÀÌ¼Ö¾Ï Á¤ÁعÎ(-)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:20~16:24 ÃÊ·Ï Raise an issue with representative cases ÀÌÁß¼±(À»ÁöÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:24~16:37 ÃÊ·Ï Oral and topical medication for a red face: My pearls ±èÇý¼º(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 16:37~16:50 ÃÊ·Ï When and how to apply EBD on a red face Á¤º¸¿µ(ÇѸ²ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 16:50~17:00 Panel discussion ÀÌÁß¼± ±èÇý¼º Á¤º¸¿µ(-)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:30~13:45 ÃÊ·Ï Systematic approach and work-up of cutaneous vasculitis ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:45~14:00 ÃÊ·Ï Management of refractory cutaneous vasculopathy Á¶¼Ò¿¬(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 14:00~14:20 ÃÊ·Ï Laser pearl of common but troublesome vascular lesions ¿Àâ±Ù(¿ÀÁîÇǺΰú)

Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 14:20~14:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:00~15:30 ÃÊ·Ï Practical applications of ultrasound in dermatology, Video training ±è¿µÈ£(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:30~15:50 ÃÊ·Ï Imaging work-up in skin cancer patients ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 15:50~16:00 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:00~16:30 ÃÊ·Ï Next generation sequencing for diagnosing neurofibromatosis and cafe-au-lait macule ½ÅÇöÅÂ(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:30~17:00 ÃÊ·Ï Gene therapy as a paradigm change in medicine ±è¿¬¼ö(Ãæ³²´ë ½Å¾àÀü¹®´ëÇпø)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 12:30~12:43 ÃÊ·Ï Types and mechanisms of zoster and other vaccines Á¤ÀÇÇö(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 12:43~13:02 ÃÊ·Ï Con ½Å±âÇõ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 13:02~13:21 ÃÊ·Ï Pro ÃÖÁ¾¿ø(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ »çÆÄÀ̾î 13:21~13:30 Debates Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:00~16:18 ÃÊ·Ï Alopecia, skin cancer ¿øÁ¾Çö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:18~16:36 ÃÊ·Ï Psoriasis, dermatitis ¹ÚÁؼö(´ë±¸°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:36~16:54 ÃÊ·Ï Acne, rosacea, hidradenitis suppurativa, and etc. ±èÁ¤Àº(¼øõÇâÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 16:54~17:00 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:00~10:05 Overview Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:05~10:20 ÃÊ·Ï Cutaneous adverse effects of chemotherapeutic drugs ¹Ú»óÇö(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:20~10:35 ÃÊ·Ï Cutaneous adverse effects of targeted therapies Á¶¼ºÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:35~10:50 ÃÊ·Ï Cutaneous adverse effects of immune checkpoint inhibitors º¯Áö¿ø(ÀÎÇÏÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 10:50~11:00 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:30~12:35 Overview Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:35~12:50 ÃÊ·Ï Biomarkers in psoriasis and psoriatic arthritis ±èÀ±¼·(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 12:50~13:05 ÃÊ·Ï Multi-morbidity of psoriasis: What dermatologists should know Á¤ÇýÁ¤(±¹¸³Áß¾ÓÀÇ·á¿ø)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:05~13:20 ÃÊ·Ï Educating and engaging patients in treatment Á¤°æÀº(Ãæ³²ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:20~13:30 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:30~13:35 Overview Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:35~13:50 ÃÊ·Ï The concept of disease modification in atopic dermatitis ³ªÂùÈ£(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 13:50~14:05 ÃÊ·Ï The identification biomarkers and prediction of treatment response in AD Àå¿ëÇö(°æºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 14:05~14:20 ÃÊ·Ï Update on the novel treatment of atopic dermatitis ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 14:20~14:30 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:00~16:05 Overview Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:05~16:20 ÃÊ·Ï Practical tips for effective phototherapy in dermatology ¿À»óÈ£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:20~16:35 ÃÊ·Ï Ensuring safety in phototherapy through understanding photosensitive conditions ¹æöȯ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:35~16:50 ÃÊ·Ï Application of home-based phototherapy for skin disorders based on the effects and side effects Á¤±âÇå(°æÈñÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 16:50~17:00 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:00~09:10 ÃÊ·Ï Surgical anatomy of head and neck ¿Àº´È£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:10~09:20 ÃÊ·Ï Local and regional anesthesia ÃÖ¿µÁØ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:20~09:30 ÃÊ·Ï Various biopsy methods and suture technique º¯Áö¿ø(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:30~09:40 ÃÊ·Ï How to design and perform basic two layer wound closure ±èÈƼö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ »çÆÄÀ̾î 09:40~11:00 ÃÊ·Ï Let¡¯s master conventional two layer wound closure! ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:30~14:20 ÃÊ·Ï How to improve the journals published by the Korean Dermatological Association ÀÌÀº¼Ò(¾ÆÁÖÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:20~14:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:00~15:50 ÃÊ·Ï Grateful journey as a dermatologic surgeon in Korea Á¤±â¾ç(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:50~16:00 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 09:00~10:00 Managements of STD and changes of surveillance system for syphilis À̼öÁø(ºÎ»êÀÇ´ë °¨¿°³»°ú) Çʼö

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 15:00~16:00 Medical disputes: What dermatologists need to know À¯È­Áø(À¯È­Áøº¯È£»ç »ç¹«½Ç) Çʼö

±âŸ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:00~08:10 Àλ縻 °­ÈÆ(ȸÀå)

±âŸ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:10~08:40 ´ëÇÑÇǺΰúÇÐȸ ¼Ò°³ À±»ó¿õ(Ãѹ«ÀÌ»ç)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 08:40~09:20 ÇǺΰú Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã ¸ñÇ¥ ¹× ³»¿ë ¾ÈÈ¿Çö(±³À°ÀÌ»ç)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 09:20~10:00 ÇǺΰú Àü°øÀÇ ¼ö·Ã °úÁ¤ÀÇ Æò°¡ ¾ÈÈ¿Çö(±³À°ÀÌ»ç)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 10:00~10:40 ÇǺΰú Àü¹®ÀÇ ÀڰݽÃÇè (2025) °³¿ä ¿À»óÈ£(°í½ÃÀÌ»ç)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 10:40~11:20 Àü¹®ÀÇ ÀڰݽÃÇè ¹Ù¸£°Ô ÃâÁ¦Çϱâ!! ¹Ú¿µ¹Î(°í½ÃÀ§¿øÀå)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 11:20~12:00 ³í¹®ÀÛ¼º¹ý ÀÌ°æÈ£(°£ÇàÀÌ»ç)

Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 12:00~12:10 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:10~11:15 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:15~11:55 ÃÊ·Ï First-in-class and only selective allosteric TYK2 inhibitor Akimichi Morita(Nagoya City University Graduate School of Medical Sciences)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:55~12:10 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:10~11:15 Introduction Chair(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:15~11:50 ÃÊ·Ï Unleashing the power of dual inhibition and IL-4 blockade by dupilumab in AD and PN °íÇöâ(ºÎ»êÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 11:50~12:00 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:00~08:05 Introduction -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:05~08:25 ÃÊ·Ï Reality Check - Achieving complete clear skin in psoriasis with biologics in real-life setting ¹ÚÁؼö(´ë±¸°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:25~08:45 ÃÊ·Ï Spotlighting itch - Considering persistent itch when making treatment decisions for your AD patients À̵¿ÈÆ(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëAB 08:45~09:00 Q&A -(-)

±âŸ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:00~08:05 Introduction -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:05~08:25 ÃÊ·Ï A durable, safe and simple journey to completely clear skin with risankizumab Á¶¼ºÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:25~08:45 ÃÊ·Ï An early, safe and lasting journey to minimal AD control with upadacitinib ¹Úâ¿í(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ Å©¸®½ºÅ»º¼·ëC 08:45~09:00 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 12:30~13:10 ÃÊ·Ï Precise diagnosis of onychomycosis and latest treatment guideline update °­ÇöÁö(Áß¾Óº¸Èƺ´¿ø)

Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 13:10~13:30 Q&A -(-)

±³À°½Ã°£ 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 13:30~14:10 ÃÊ·Ï Considerations of DMF for psoriasis in real world experience Á¤±âÇå(°æÈñÀÇ´ë)

Åä·Ð 04¿ù 18ÀÏ ¿¡¸Þ¶öµå 14:10~14:30 Q&A -(-)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-04-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦13Â÷ Çмú Áý´ãȸ : 2024-04-18
´ÙÀ½±Û 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 76 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 39 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 45 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 34 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 25 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 22 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 30 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 24 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 16 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 28 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 31 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 32 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 39 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷